Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Alphabet Stock’s Weakness Was Wall Street’s Opportunity

Over the past 12 months, institutions bought $126.6 billion worth of Alphabet stock, with a net inflow of $69B despite regulatory and competitive headwinds.

MarketBeat

The Utilities Stock at the Center of AI and Rising Electric Bills

AI data centers are causing American’s utility bills to soar. As demand continues to surge, utility companies will reap the benefits.

MarketBeat

Oracle Has Spoken: AI Changes Everything

Oracle is on track to rise above $400 as AI and hyperscaler data center demand drive a ballooning RPO and revenue growth outlook.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Beyond DIY: Home Depot's Conquest of the Professional Market

Home Depot’s massive acquisitions of SRS and GMS forge a new B2B titan, aiming to dominate every phase of the professional construction project.

MarketBeat

3 Plays on Gold in Case Trust in the Fed Slips

With the price of gold already rallying and set to jump even further, these three investments could set investors up to reap big rewards.

MarketBeat

CoreWeave and Madrigal's Insider Trades Flash Bullish Signals

Insider trades at NVIDIA-backed CoreWeave and Madrigal Pharmaceuticals are bullish indicators, but for very different reasons.

MarketBeat

August's Most Upgraded: 3 Stocks With +20 Price Target Increases

See which three stocks received the most analyst upgrades in August. All three posted fantastic earnings, exciting investors and Wall Street forecasters alike.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Is Qualcomm Tesla’s Next Rival in Autonomous Driving?

Tesla may still dominate the autonomous headlines, but Qualcomm’s partnership with BMW make it an interesting alternative for investors to consider.

MarketBeat

3 Under-the-Radar Biotechs Under $5 That Could Soar 200%

3 biotech stocks under $5 with cancer, obesity, and psychedelic therapies offer speculative investors high-risk, high-reward potential: HOTH, SILO, and ANIX.

MarketBeat

The Quiet Before the Catalyst: Vertical Aerospace's Next Move

Vertical Aerospace's investor day is poised to reveal its financial roadmap, a new catalyst for the stock following a summer of proven operational progress.

MarketBeat

These 4 Mid-Caps Just Announced Big Buyback Plans

See which four mid-cap stocks just announced huge new buyback programs, with one firm now having buyback capacity equal to more than 12% of its market cap.

MarketBeat

Ulta Beauty Stock: Strong Growth, Short-Term Volatility Ahead

ULTA shares are up nearly 20% this year after several strong earnings reports. Are there more gains ahead, or is the upside beginning to get tapped out?

MarketBeat

Should You Buy Figma Stock After Its 55% Post-IPO Drop?

Adobe challenger Figma has cooled down after an incredibly hot start as a public company. Should investors take advantage of this high-growth stock's 55% fall?

MarketBeat

Casey’s General Stores: Investors Win With CASY at the Bat

Casey's General Stores is a must-own quality stock on track to hit new highs in 2025 and 2026 as self-funded growth drives cash flow and capital returns.

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

3 Potential Rate Cut Winners for Your Portfolio

With the Federal Reserve set to cut interest rates during September 2025, there are certain companies that will see the most benefit in their balance sheets.

MarketBeat

Joby's Stock Is Quiet, But a Storm of Catalysts Is Brewing

Joby Aviation's stock consolidation overlooks a series of major catalysts, including a landmark defense demonstration that expands its long-term potential.

MarketBeat

Mortgage Pressures Ease, 3 Stocks to Rally on Lower Rates

As mortgage rates start to come down ahead of the big Fed decision, these three stocks show several signs of running into new highs shortly.

MarketBeat

Take the Money and Run: Strategy Stock Looks Tapped Out

Strategy stock is being seen as riskier in today's market environment, despite the potential for rate cuts coming from the Fed, a warning sign for investors.

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Novartis' Moonshot Cancer Therapy Could Be Future Growth Driver

Novartis is betting big on radioligand cancer therapy, but while the long-term growth story looks strong, NVS stock may face a short-term pullback

MarketBeat

Why These Banking Stocks Could Soar on Rate Cuts

As markets prepare for the Fed to cut interest rates in the United States, savvy investors will position their portfolios in these banking stocks.

MarketBeat

3 Big Dividend Hikes Hit the Market—1 Just Doubled Its Payout

One of the biggest names in sports entertainment just doubled its dividend. Two tech giants also announced significant dividend increases.

MarketBeat

What NVIDIA’s Big Bet on Rival Quantinuum Means for D-Wave Stock

Honeywell's quantum joint venture, Quantinuum, recently announced a big influx of cash from NVIDIA and others; what does this mean for rivals like D-Wave?

MarketBeat

3 Undervalued Stocks Poised to Shine in the Next Market Rally

As rate cuts are around the corner, it is clear that some names will start to do well, especially ones that now trade at discounted prices.

MarketBeat

Why CAVA Is the Dip Buy to Outperform Chipotle

Both CAVA and Chipotle have fallen significantly this year, though only one should be considered the dip-buying opportunity by investors.

MarketBeat

Insiders Sell These High-Quality Stocks: Why Investors Shouldn’t

Insiders are selling stocks like Dell Technologies, Snowflake, and Chewy but investors shouldn't because they are delivering value and have robust upsides ahead

1 … 78 79 80 81

People

Michael Dell

160 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.